General Archive

-
News releasesLifeArc and the Gates Foundation launches groundbreaking new projects to lower the cost of monoclonal antibody production
We have partnered with the Gates Foundation to fund seven new projects aimed at reducing the costs of manufacturing monoclonal…
-
News releasesLifeArc joins transatlantic collaboration to develop a treatment for Crimean-Congo Hemorrhagic Fever
A new transatlantic collaboration between the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and LifeArc will look to…
-
News releasesLifeArc and Cleveland Clinic join forces to develop new monoclonal antibody therapeutics for patients with high unmet medical needs
LifeArc and Cleveland Clinic, a nonprofit, multispecialty academic medical centre, have signed a new 10-year Master Services Agreement (MSA) for…
-
News releases
MRC Technology highlights presentation of data for antibody candidate lambrolizumab developed using its humanization technology
The humanized antibody is now being developed by MSD, known as Merck in the US and Canada. Lambrolizumab is an…
